Skip to content

Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants

Status
Suspended
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-513069-37-00
Acronym
MS201491_0001
Enrollment
49
Registered
2024-08-09
Start date
2024-08-21
Completion date
Unknown
Last updated
2026-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Interventions

None listed

Sponsors

Merck Healthcare KGaA
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

Germany

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026